Oluwaseyi Olabige

发表

A ten-gene DNA-damage response pathway gene expression signature predicts gemtuzumab ozogamicin response in pediatric AML patients treated on COGAAML0531 and AAML03P1 trials

R. Ries, S. Meshinchi, T. Alonzo, 2022, Leukemia.